drugset
drugset / Trial / NCT04297865

Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CJ-15314 Phosphate in Healthy Male Subjects

NCT04297865 ↗

Phase 1 Unknown 55 enrolled HK inno.N Corporation
RandomizedSequentialQuadruple-blindTreatment

Summary

This study aims to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of CJ-15314 phosphate in healthy male subjects.

Timeline

Start
2020-02-24
Primary completion
2021-01
Completion
2021-02

Drugs

EvaluationDrugModalityDoseRoute
Subject CJ-15314 Unknown — Oral

Indications

No indication recorded.